Company research / CRMD

CorMedix Inc. (CRMD)

CIK 0001410098 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, CorMedix Inc. reported revenue of $311.71M. Revenue grew 617.0% from the prior annual period.

Key ratios (year ended 2025-12-31)

88.5%
Gross margin
48.2%
Operating margin
52.3%
Net margin
40.2%
Return on year-end equity
617.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 4 · 2026-09-01

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.